Simplex Trading
CADL icon

Simplex Trading’s Candel Therapeutics CADL Stock Holding History

Simplex Trading’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.8K Buy
+13,216
New +$71.9K ﹤0.01% 5576
2025
Q2 		– Sell
-17,107
Closed -$88K – 8692
2025
Q1 		$96K Buy
17,107
+12,538
+274% +$102K ﹤0.01% 5093
2024
Q4 		$39K Sell
4,569
-18,269
-80% -$108K ﹤0.01% 6108
2024
Q3 		$158K Buy
22,838
+17,837
+357% +$111K ﹤0.01% 4755
2024
Q2 		$31K Buy
+5,001
New +$37.5K ﹤0.01% 6523

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's CADL Position: Q1 2026 in Review

Simplex Trading opened a new position in Candel Therapeutics (CADL) in Q1 2026: 13,216 shares worth $64.8K. The stake represents ﹤0.01% of the portfolio and ranks #5576 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CADL as recently as Q1 2025.

Simplex Trading first reported a position in CADL in Q2 2024 and has held it in 5 quarters since. The position peaked at $158K in Q3 2024. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • Simplex Trading held 13,216 shares of Candel Therapeutics worth $64.8K as of Q1 2026.
  • Candel Therapeutics was a new Simplex Trading position in Q1 2026.
  • Candel Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5576 holding.
  • Simplex Trading first reported a position in Candel Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • Simplex Trading's Candel Therapeutics position peaked at $158K in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.